๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Prostate Cancer Recurrent

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned. NCT05946824Phase 21 site๐Ÿ“ Rochester University of Rochester ยท Tests: Daily-adaptive Stereotactic Body Radiation Therapy, Daily-adaptive Stereotactic Body Radiation Therapy Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer NCT05753566Phase 22 sites๐Ÿ“ Nanjing๐Ÿ“ Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Univeโ€ฆ ยท Tests: Rezvilutamide, Androgen deprivation therapy (ADT), SRT Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy NCT07711314Phase 21 site๐Ÿ“ Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Univeโ€ฆ ยท Tests: Rezvilutamide Tablets An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. NCT05939414Phase 3144 sites๐Ÿ“ Fayetteville๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto Novartis Pharmaceuticals ยท Tests: AAA617, piflufolastat (18F), gallium (68Ga) gozetotide (25ฮผg) A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) NCT07723248Phase 312 sites๐Ÿ“ Coral Springs๐Ÿ“ Jeffersonville๐Ÿ“ Holland ORIC Pharmaceuticals ยท Tests: Rinzimetostat, Darolutamide, Enzalutamide, Docetaxel Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer NCT07667400Phase 1, Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: SX-682, DTX PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer NCT07234981Phase 21 site๐Ÿ“ Omaha University of Nebraska ยท Tests: PSMA-guided Salvage Radiation PSMA-RLT in Biochemically Recurrent PCa NCT06220188Phase 21 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: [177Lu]Lu-PSMA I&T Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era NCT06508567NA1 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: High Dose Rate Brachytherapy Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy NCT06201078Phase 21 site๐Ÿ“ Gliwice Maria Sklodowska-Curie National Research Institute of Oncolโ€ฆ ยท Tests: Stereotactic Body Radiotherapy An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial NCT06813898EARLY Phase 11 site๐Ÿ“ Chicago Northwestern University ยท Tests: Computed Tomography, Electronic Health Record Review, Flotufolastat F-18 Gallium, Positron Emission Tomography Salvage HDR for Locally Recurrent Prostate Cancer NCT04231006NA1 site๐Ÿ“ Aarhus Aarhus University Hospital ยท Tests: High dose rate brachytherapy Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy NCT07792993n/a1 site๐Ÿ“ Rome Regina Elena Cancer Institute Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. NCT07483658NA4 sites๐Ÿ“ Gatineau๐Ÿ“ Montreal๐Ÿ“ Montreal CHU de Quebec-Universite Laval ยท Tests: Standard Fractionation Post-Operative Salvage Radiotherapy (25 fractions), Hypofractionated Post-Operative Salvage Radiโ€ฆ Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II) NCT07142967NA1 site๐Ÿ“ New York NYU Langone Health ยท Tests: Stereotactic Body Radiation Therapy (SBRT), Androgen Deprivation Therapy (ADT) Multi-peptide Vaccination and Bispecific PSMAxCD3 Antibody Treatment in Patients With Prostate Cancer NCT07860047Phase 24 sites๐Ÿ“ Heidelberg๐Ÿ“ Tรผbingen๐Ÿ“ Berlin University Hospital Tuebingen ยท Tests: PSMAxCD3, bispecific antibody CC-1, Multipeptide Vaccine VAC-XS15-PC01 A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation NCT06952803Phase 3346 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ La Jolla AstraZeneca ยท Tests: Saruparib, Placebo, Abiraterone + Prednisolone/Prednisone, Androgen Deprivation Therapy (ADT) A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors NCT06465069Phase 139 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Eli Lilly and Company ยท Tests: LY4052031, Pembrolizumab 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer NCT04857502EARLY Phase 11 site๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: 99mTc-based PSMA Imaging and Surgery Agent, Computed Tomography, Single Photon Emission Computed Tomography Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy. NCT06523634NA13 sites๐Ÿ“ Aalst๐Ÿ“ Antwerp๐Ÿ“ Bruges Jules Bordet Institute ยท Tests: Stereotactic body radiotherapy (SBRT), SOC RT Detection of Minimal Residual Disease Post-prostatectomy NCT07334275n/a1 site๐Ÿ“ Nijmegen Radboud University Medical Center Barrigelยฎ PPRT (Post-Prostatectomy Radiation Therapy) Trial NCT06496256NA13 sites๐Ÿ“ Chandler๐Ÿ“ Santa Barbara๐Ÿ“ Boca Raton Palette Life Sciences, Inc. ยท Tests: Barrigel, Transrectal Ultrasound A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET NCT06859203n/a2 sites๐Ÿ“ Augsburg๐Ÿ“ Munich Technical University of Munich Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence NCT06941363n/a1 site๐Ÿ“ Monza University of Milano Bicocca ยท Tests: SDRT Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer NCT05328505NA2 sites๐Ÿ“ London๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Image-guided Radiotherapy Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging NCT04423211Phase 3341 sites๐Ÿ“ Anchorage๐Ÿ“ Anchorage๐Ÿ“ Anchorage ECOG-ACRIN Cancer Research Group ยท Tests: 3-Dimensional Conformal Radiation Therapy, Apalutamide, Computed Tomography, Degarelix, External Beam Radiation Therapy Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence NCT07569926Phase 46 sites๐Ÿ“ San Diego๐Ÿ“ Atlanta๐Ÿ“ Boston Blue Earth Diagnostics ยท Tests: fluciclovine (18F) Metastasis-directed Therapy for Oligorecurrent Prostate Cancer NCT05352178Phase 31 site๐Ÿ“ Leuven Universitaire Ziekenhuizen KU Leuven ยท Tests: Radiotherapy (SBRT) and/or surgery (metastasectomy), Androgen deprivation therapy, Androgen receptor targeted therapy MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer NCT05241236n/a1 site๐Ÿ“ Miami Lakes Urological Research Network, LLC ยท Tests: Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities NCT07690579n/a1 site๐Ÿ“ San Francisco University of California, San Francisco ยท Tests: Questionnaires, Medical Record Review
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy